Media Summary: Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment. Cathy Eng, MD, FACP, FASCO, of Vanderbilt-Ingram Cancer Center, provides her thoughts on Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses

Advancing Ctdna As An Early - Detailed Analysis & Overview

Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment. Cathy Eng, MD, FACP, FASCO, of Vanderbilt-Ingram Cancer Center, provides her thoughts on Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses 00:00 - Meeting Begins 03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal 19:53 - Panel 1: Leveraging Learnings from ... Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold ...

Can a blood test really detect breast cancer recurrence before scans do? In this video, Dr. Jennifer Griggs explains liquid biopsy ... In this segment, Dr. Frank Weinberg explores how Maen Abdelrahim, MD, PhD, of Houston Methodist Neal Cancer Center, discusses emerging research on the use of personalized, ...

Photo Gallery

Advancing ctDNA as an Early Endpoint Marker in Solid Tumors
Understand ctDNA Testing
Utility of ctDNA in Early-Stage, Advanced Colon Cancer
What is Circulating Tumor DNA (ctDNA)?
Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute
Expediting Drug Development: Use of ctDNA as an Early Endpoint
Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis
2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute
2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum
Using circulating tumor DNA (ctDNA) for the early detection of cancer.
Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?
How ctDNA Is Changing Early Stage Lung Cancer Monitoring And Treatment Decisions – Dr. Frank Weinber
Sponsored
Sponsored
View Detailed Profile
Advancing ctDNA as an Early Endpoint Marker in Solid Tumors

Advancing ctDNA as an Early Endpoint Marker in Solid Tumors

Circulating tumor DNA

Understand ctDNA Testing

Understand ctDNA Testing

Important Note: This video is for your information only. Do not use these videos for medical advice, diagnosis, or treatment.

Sponsored
Utility of ctDNA in Early-Stage, Advanced Colon Cancer

Utility of ctDNA in Early-Stage, Advanced Colon Cancer

Cathy Eng, MD, FACP, FASCO, of Vanderbilt-Ingram Cancer Center, provides her thoughts on

What is Circulating Tumor DNA (ctDNA)?

What is Circulating Tumor DNA (ctDNA)?

For more info, visit: https://www.primrmed.com/cancer/general

Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute

Circulating Tumor DNA (ctDNA) in Early Breast Cancer | Dana-Farber Cancer Institute

Stefania Morganti, MD, a researcher in the Breast Oncology Program, discusses

Sponsored
Expediting Drug Development: Use of ctDNA as an Early Endpoint

Expediting Drug Development: Use of ctDNA as an Early Endpoint

00:00 - Meeting Begins 03:06 - Fireside Chat with Patrizia Cavazzoni and Ellen Sigal 19:53 - Panel 1: Leveraging Learnings from ...

Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis

Circulating Tumor DNA Tests for Early Stage Cancer Diagnosis

The blood-based test for

2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute

2025 SABCS Highlights: Advances in ctDNA for Breast Cancer | Dana-Farber Cancer Institute

Harold Burstein, MD, PhD, and Ilana Schlam, MD, MPH, discuss important advances in

2025 HOPA Conference:  Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

2025 HOPA Conference: Utility of Circulating Tumor DNA ctDNA Across the Cancer Care Continuum

Learning Objectives: Describe

Using circulating tumor DNA (ctDNA) for the early detection of cancer.

Using circulating tumor DNA (ctDNA) for the early detection of cancer.

The team in the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins has developed and is currently testing a bold ...

Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?

Circulating Tumor DNA: The Blood Test That Detects Cancer Before Scans?

Can a blood test really detect breast cancer recurrence before scans do? In this video, Dr. Jennifer Griggs explains liquid biopsy ...

How ctDNA Is Changing Early Stage Lung Cancer Monitoring And Treatment Decisions – Dr. Frank Weinber

How ctDNA Is Changing Early Stage Lung Cancer Monitoring And Treatment Decisions – Dr. Frank Weinber

In this segment, Dr. Frank Weinberg explores how

Early Detection, Better Decisions: ctDNA as a Tool for Curative HCC Management

Early Detection, Better Decisions: ctDNA as a Tool for Curative HCC Management

Maen Abdelrahim, MD, PhD, of Houston Methodist Neal Cancer Center, discusses emerging research on the use of personalized, ...